PPCB
Propanc Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · AU
$0.32
−7.31%Leverage
- Debt / equity
- 0.05x
- Net debt / equity
- -0.03x
- Debt / assets
- 0.04x
- Debt / EBITDA
- -0.03x
- Net debt / EBITDA
- 0.02x
Liquidity & coverage
- Current ratio
- 2.55x
- Quick ratio
- 2.55x
- Cash ratio
- 0.25x
- Interest coverage
- -42.24x
- EBITDA / interest
- -40.23x
- Working capital
- $5.2M
Cash & dividend
- FCF / debt
- -11.37x
- Cash flow / debt
- -11.37x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026